This week Flibanserin (Addyi) was approved by the FDA, making it the first medication prescribed for decreased female libido otherwise known as female hypoactive sexual desire disorder (HSDD).
Decreased libido has been less of an issue for men. Male sexual dysfunction has focused on erectile dysfunction. Multiple medications have been FDA approved for erectile dysfunction. Viagra, the first of such medications, was approved by the FDA in 1998.
The results with Flibanserin are not impressive. It was only tested on premenopausal women. It requires daily use. There are side effects. But it is a start.
FDA approval of Flibanserin (Addyi) is a small step in the right direction. Female sexuality is complex. We need to continue the conversation and the research on female sexuality.